Bulletin
Investor Alert

New York Markets Close in:

Alkermes PLC

NAS: ALKS

GO
/marketstate/country/us

Market open

/zigman2/quotes/205084517/composite

$

25.27

Change

-0.35 -1.35%

Volume

Volume 456,042

Aug 18, 2022, 1:34 p.m.

Real time quotes

/zigman2/quotes/205084517/composite

Previous close

$ 25.61

$ 25.27

Change

-0.35 -1.35%

Day low

Day high

$25.19

$25.78

Open
Open: 25.72

52 week low

52 week high

$21.24

$33.00

Open

Market cap

$4.21B

Average volume

1.56M

P/E ratio

N/A

Rev. per Employee

$530,696

EPS

-0.58

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/alks

MarketWatch News on ALKS

  1. How to Avoid the Biotech Bear Market: Get Some Products Approved

    9:33 p.m. May 13, 2022

    - Barron's Online

  2. Nektar Shares Halve on Cancer Trial Failure

    6:14 p.m. March 14, 2022

    - Barron's Online

  3. Alkermes downgraded to underperform from neutral at BofA Securities

    9:41 a.m. Sept. 2, 2021

    - Tomi Kilgore

  4. Alkermes stock halted for news pending

    7:00 a.m. June 1, 2021

    - Tomi Kilgore

  5. Biotech Is Down. How It Could Come Back.

    9:41 a.m. May 17, 2021

    - Barron's Online

  6. The Case for AbbVie as a Top Biopharma Stock in 2021

    9:45 a.m. Jan. 7, 2021

    - Barron's Online

  7. Alkermes upgraded to buy from neutral at Mizuho

    6:35 a.m. Oct. 15, 2020

    - Tomi Kilgore

  8. Alkermes stock price target raised to $24 from $19 at Mizuho

    6:04 a.m. Oct. 15, 2020

    - Tomi Kilgore

  9. Alkermes downgraded to neutral from buy at BofA Securities

    11:40 a.m. Feb. 14, 2020

    - Tomi Kilgore

  10. Alkermes stock price target cut to $20 from $31 at BofA Securities

    11:40 a.m. Feb. 14, 2020

    - Tomi Kilgore

  11. Alkermes downgraded to neutral from overweight at J.P. Morgan

    8:51 a.m. Feb. 14, 2020

    - Tomi Kilgore

  12. Alkermes stock price target cut to $21 from $25 at J.P. Morgan

    8:52 a.m. Feb. 14, 2020

    - Tomi Kilgore

  13. FDA told Alkermes to stop publishing Vivitrol ad

    1:12 p.m. Dec. 11, 2019

    - Jaimy Lee

  14. Alkermes to acquire Rodin Therapeutics for up to $950 million

    8:30 a.m. Nov. 18, 2019

    - Ciara Linnane

  15. Biogen shares fall 3%

    4:08 p.m. Nov. 14, 2019

    - Jaimy Lee

  16. Biogen, Alkermes MS treatment Vumerity gets FDA approval

    7:33 a.m. Oct. 30, 2019

    - Tomi Kilgore

  17. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/alks

Other News on ALKS

  1. Intercept (ICPT) Settles Litigation With Dr. Reddy's for Ocaliva

    10:20 a.m. Today

    - Zacks.com

  2. GSK NDA for Myelofibrosis Candidate Gets FDA Acceptance

    8:46 a.m. Today

    - Zacks.com

  3. AbbVie (ABBV) Outperforms Industry This Year So Far: Here's Why

    8:40 a.m. Today

    - Zacks.com

  4. AstraZeneca's (AZN) Lynparza sNDA Gets FDA Priority Tag

    8:50 a.m. Aug. 16, 2022

    - Zacks.com

  5. Are Medical Stocks Lagging Alkermes (ALKS) This Year?

    9:40 a.m. Aug. 15, 2022

    - Zacks.com

  6. Here's Why You Should Buy Patterson Companies (PDCO) Stock

    10:33 a.m. Aug. 12, 2022

    - Zacks.com

  7. Roche (RHHBY) Influenza Drug Gets FDA Nod for Children

    10:33 a.m. Aug. 12, 2022

    - Zacks.com

  8. 3 Companies Growing Revenue Fast

    1:23 p.m. Aug. 10, 2022

    - GuruFocus.com

  9. Perrigo's (PRGO) Q2 Earnings Misses by a Cent, Sales Beat

    12:14 p.m. Aug. 9, 2022

    - Zacks.com

  10. Loading more headlines...
/news/pressrelease/company/us/alks

Press Releases on ALKS

  1. Alkermes plc Reports Second Quarter 2022 Financial Results

    7:00 a.m. July 27, 2022

    - PR Newswire - PRF

  2. Alkermes to Report Second Quarter Financial Results on July 27, 2022

    4:00 p.m. July 20, 2022

    - PR Newswire - PRF

  3. Sarissa Capital Comments on Alkermes Annual Meeting

    7:04 a.m. July 6, 2022

    - BusinessWire - BZX

  4. Alkermes to Participate in the Goldman Sachs Healthcare Conference

    4:00 p.m. June 8, 2022

    - PR Newswire - PRF

  5. Alkermes to Participate in the Jefferies Healthcare Conference

    4:00 p.m. June 1, 2022

    - PR Newswire - PRF

  6. Sarissa Condemns Poor Corporate Governance at Alkermes

    9:43 a.m. May 27, 2022

    - BusinessWire - BZX

  7. Alkermes to Report First Quarter Financial Results on April 27, 2022

    4:00 p.m. April 20, 2022

    - PR Newswire - PRF

  8. Alkermes to Participate in the Stifel 2022 CNS Days

    4:00 p.m. March 22, 2022

    - PR Newswire - PRF

  9. Loading more headlines...

Rates »

Link to MarketWatch's Slice.